Article Text

Download PDFPDF
Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias

Abstract

Aim: To evaluate the clinical outcome of patients in whom ocular surface reconstruction was performed using amniotic membrane transplantation (AMT) after the excision of large (>20 mm square) ocular surface neoplasias (OSN).

Methods: A non-comparative interventional case series. In 16 eyes of 16 patients, excision of large OSN including conjunctival intraepithelial neoplasia (CIN), primary acquired melanosis, and malignant melanoma was followed by adjunctive cryotherapy and suturing of a single layer of amniotic membrane (AM) with the basement membrane side facing up to the healthy bordering tissue. Epithelial healing, complications, and tumour recurrences were analysed.

Results: During a mean follow up of 23.7 (SD 11, range 11–43) months, ocular surface healing was rapid and complete in all cases. One complication of pyogenic granuloma was noted. Tumour recurrence occurred in one out of 10 CIN cases (10%), no recurrences were observed in the patients with melanotic lesions.

Conclusions: AMT in lieu of conjunctival or mucosal autograft is an effective substrate for reconstructing the ocular surface following excision of large OSN. AMT is effective in managing large OSN by avoiding the complications that may be associated with conventional removal, specifically in cases where the limbal architecture is destroyed by surgical resection or adjuvant therapies.

  • amniotic membrane transplantation
  • excision
  • ocular surface neoplasias
  • AM, amniotic membrane
  • AMT, amniotic membrane transplantation
  • CIN, conjunctival intraepithelial neoplasia
  • CMM, conjunctival malignant melanoma
  • PAM, primary acquired melanosis
  • VA, visual acuity
  • amniotic membrane transplantation
  • excision
  • ocular surface neoplasias
  • AM, amniotic membrane
  • AMT, amniotic membrane transplantation
  • CIN, conjunctival intraepithelial neoplasia
  • CMM, conjunctival malignant melanoma
  • PAM, primary acquired melanosis
  • VA, visual acuity

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.